Anja Schafer

Basel, BS 4001, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The essential malaria protein PfCyRPA targets glycans to invade erythrocytes.

The essential malaria protein PfCyRPA targets glycans to invade erythrocytes.

Journal: Cell reports

Published: July 27, 2023

The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals.

The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals.

Journal: Malaria journal

Published: March 07, 2023

Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate.

Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate.

Journal: Frontiers in bioengineering and biotechnology

Published: February 18, 2022

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans.

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans.

Journal: PLoS neglected tropical diseases

Published: November 24, 2019

Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models.

Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models.

Journal: NPJ vaccines

Published: October 03, 2019

Potent Inhibitors of Plasmodial Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold.

Potent Inhibitors of Plasmodial Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold.

Journal: ChemMedChem

Published: January 23, 2018

Conformational Aspects in the Design of Inhibitors for Serine Hydroxymethyltransferase (SHMT): Biphenyl, Aryl Sulfonamide, and Aryl Sulfone Motifs.

Conformational Aspects in the Design of Inhibitors for Serine Hydroxymethyltransferase (SHMT): Biphenyl, Aryl Sulfonamide, and Aryl Sulfone Motifs.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: July 13, 2017

Antimalarial Inhibitors Targeting Serine Hydroxymethyltransferase (SHMT) with in Vivo Efficacy and Analysis of their Binding Mode Based on X-ray Cocrystal Structures.

Antimalarial Inhibitors Targeting Serine Hydroxymethyltransferase (SHMT) with in Vivo Efficacy and Analysis of their Binding Mode Based on X-ray Cocrystal Structures.

Journal: Journal of medicinal chemistry

Published: May 25, 2017

An amphiphilic graft copolymer-based nanoparticle platform for reduction-responsive anticancer and antimalarial drug delivery.

An amphiphilic graft copolymer-based nanoparticle platform for reduction-responsive anticancer and antimalarial drug delivery.

Journal: Nanoscale

Published: July 26, 2016

Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation.

Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation.

Journal: Journal of medicinal chemistry

Published: January 29, 2016

Small molecules, peptides and natural products: getting a grip on 14-3-3 protein-protein modulation.

Small molecules, peptides and natural products: getting a grip on 14-3-3 protein-protein modulation.

Journal: Future medicinal chemistry

Published: June 26, 2014

Stabilization of protein-protein interactions by small molecules.

Stabilization of protein-protein interactions by small molecules.

Journal: Drug discovery today

Published: March 26, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026